To improve the efficiency and precision of our pharmacy consultation services,we adopted a"1+X"model based on the PDCA(Plan-Do-Check-Act)cycle.In the initial analysis,we identified factors contributing to su...To improve the efficiency and precision of our pharmacy consultation services,we adopted a"1+X"model based on the PDCA(Plan-Do-Check-Act)cycle.In the initial analysis,we identified factors contributing to suboptimal consultation efficiency.Our approach included a thorough examination of our pharmacy consultation system,encompassing personnel training,consultation promotion,and the refinement of the consultation process.A standardized pharmacy consultation model was devised and continually refined,with a primary focus on infectious diseases.Subsequently,the model expanded to include various medical specialties,fostering multi-disciplinary participation.Since the implementation of the"1+X"pharmacy consultation model,spanning from 2017 to 2022,consultation numbers exhibited a consistent annual growth exceeding 50%.In 2022 alone,5044 pharmaceutical consultations were conducted,encompassing 3007 standard consultations and 96 expanded consultations across diverse departments such as neurosurgery and neurology.The adoption rate of consultation recommendations reached 89.2%,while the effectiveness of consultation treatments stood at an impressive 76.4%.This success underscored the impact of the"1+X"pharmacy consultation model on enhancing consultation outcomes.Collectively,our model,rooted in the PDCA cycle,not only served as a practical blueprint for pharmacy consultation systems in medical institutions but also provided valuable insights and a robust framework for the professional development and training of clinical pharmacists.展开更多
基金Jiangxi Provincial Hospital Pharmacy Special Research Fund Project(Grant No.2024-ZXYJ02)Jiangxi Provincial Department of Education Project(Grant No.200227)。
文摘To improve the efficiency and precision of our pharmacy consultation services,we adopted a"1+X"model based on the PDCA(Plan-Do-Check-Act)cycle.In the initial analysis,we identified factors contributing to suboptimal consultation efficiency.Our approach included a thorough examination of our pharmacy consultation system,encompassing personnel training,consultation promotion,and the refinement of the consultation process.A standardized pharmacy consultation model was devised and continually refined,with a primary focus on infectious diseases.Subsequently,the model expanded to include various medical specialties,fostering multi-disciplinary participation.Since the implementation of the"1+X"pharmacy consultation model,spanning from 2017 to 2022,consultation numbers exhibited a consistent annual growth exceeding 50%.In 2022 alone,5044 pharmaceutical consultations were conducted,encompassing 3007 standard consultations and 96 expanded consultations across diverse departments such as neurosurgery and neurology.The adoption rate of consultation recommendations reached 89.2%,while the effectiveness of consultation treatments stood at an impressive 76.4%.This success underscored the impact of the"1+X"pharmacy consultation model on enhancing consultation outcomes.Collectively,our model,rooted in the PDCA cycle,not only served as a practical blueprint for pharmacy consultation systems in medical institutions but also provided valuable insights and a robust framework for the professional development and training of clinical pharmacists.
